Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection
Author(s): Allen Loyd V Jr
Issue: Jul/Aug 2000 - Compounding for Hospice and Cancer Patients
View All Articles in Issue
Page(s): 296
Download in electronic PDF format for $75
Abstract: A formulation for preparing Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Categories: CANCER AND AIDS, FORMULATIONS, STABILITIES, COMPATIBILITIES